BSCL2 抗体 (AA 78-107)
Quick Overview for BSCL2 抗体 (AA 78-107) (ABIN1806206)
抗原
See all BSCL2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 78-107
- 
                                            特异性
- This BSCL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 78-107 amino acids from the N-terminal region of human BSCL2.
- 
                                            纯化方法
- Protein A purified
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: IHC, IHC-P (1:50 - 1:100), WB (1:1000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, 0.09 % sodium azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
- 
                                            别名
- BSCL2
- 
                                            背景
- 
                        Name/Gene ID: BSCL2
 Synonyms: BSCL2, GNG3LG, SPG17, HMN5, Seipin
- 
                                            基因ID
- 26580
- 
                                            UniProt
- Q96G97
 抗原
- 
                    
 
                                     
                                     
                                    